UCH-L1 expression of podocytes in diseased glomeruli and in vitro

被引:40
|
作者
Liu, Yuan [1 ,2 ,4 ]
Wu, Jiajing [1 ,2 ]
Wu, Huijuan [1 ,2 ]
Wang, Tianzhan [1 ,2 ]
Gan, Hualei [1 ,2 ]
Zhang, Xin [1 ,2 ]
Liu, Ye [1 ,2 ]
Li, Ruixi [3 ]
Zhao, Zhonghua [1 ,2 ]
Chen, Qi [1 ,2 ]
Guo, Muyi [1 ,2 ]
Zhang, Zhigang [1 ,2 ]
机构
[1] Fudan Univ, Dept Pathol, Shanghai Med Coll, Shanghai 200032, Peoples R China
[2] Fudan Univ, Key Lab Mol Med, Shanghai Med Coll, Minist Educ, Shanghai 200032, Peoples R China
[3] Fudan Univ, Dept Anat Histol & Embryol, Shanghai Med Coll, Shanghai 200032, Peoples R China
[4] Shanghai Univ Chinese Tradit Med, Putuo Hosp, Dept Pathol, Shanghai 200062, Peoples R China
关键词
ubiquitin C-terminal hydrolase-L1 (UCH-L1); podocyte; glomerulonephritis; immunocomplex; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; CARBOXYL-TERMINAL HYDROLASE; CYCLE REGULATORY PROTEINS; CELL-CYCLE; EPITHELIAL-CELLS; LUPUS-ERYTHEMATOSUS; NEPHROTIC SYNDROME; LUNG-CANCER; UBIQUITIN; PROLIFERATION;
D O I
10.1002/path.2511
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ubiquitin C-terminal hydrolase-L1 (UCH-L1), an important member of de-ubiquitination enzyme families involved in the ubiquitin-proteasome pathway, is expressed mainly in neural and reproductive systems as well as in some tumours. Recently, expression of UCH-L1 has been discovered in parietal epithelial cells of Bowman's capsules and some tubular epithelia in the kidney. However, whether UCH-L1 is expressed in the capillary tufts of the glomeruli has not yet become clear. In this study, we used immunohistochemistry, double immunofluorescence labelling, immunoelectron microscopy in kidney biopsy tissues and western blot in cultured rat podocytes to investigate the expression of UCH-L1 and the regulation of this expression in podocytes. The results demonstrated that UCH-L1 was expressed in podocytes and its expression was significantly higher in acute proliferative glomerulonephritis (APGN), lupus nephritis (LN), membranous glomerulonephritis (MGN) and IgA nephropathy than that in focal segmental glomeruloselerosis (FSGS), minimal change disease (MCD), minor abnormality and normal kidney tissues (p < 0.05). In in vitro experiments, western blot showed that UCH-L1 expression significantly increased in the two groups of podocytes co-cultured with mesangial cells exposed to ATS 50 mu l/ml and ATS 50 mu l/ml with normal human serum 30 mu l/ml, respectively (p < 0.05), while the other groups treated with TGF beta 1 1 ng/ml, TNF alpha 10 ng/ml or IL-1 10 ng/ml had little rise of UCH-L1 expression, with no statistical significance compared with normal control (P > 0.05). Further tests indicated that the percentage of PCNA-positive podocytes in LN, APGN and IgA nephropathy was significantly higher than that in MCD, FSGS and normal control (p < 0.05). These data show for the first time that podocytes do express UCH-L1 and that its expression can be increased in these immunocomplex-mediated nephrites. The immune injury is a main cause for stimulating podocytes to express UCH-L1. The expression of UCH-L1 may be associated with the regeneration of podocytes as a repair response to immunocomplex-mediated injury. Copyright (C) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:642 / 653
页数:12
相关论文
共 50 条
  • [1] Detection of UCH-L1 expression by pre-embedding immunoelectron microscopy with colloidal gold labeling in diseased glomeruli
    Liu, Yuan
    Wu, Huijuan
    Wu, Jiajing
    Wang, Suxia
    Liu, Ye
    Zhao, Zhonghua
    Zhang, Xiurong
    Li, Ruixi
    Guo, Muyi
    Zhang, Zhigang
    ULTRASTRUCTURAL PATHOLOGY, 2008, 32 (01) : 5 - 9
  • [2] UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?
    Ji-hong Cui
    Xin Xie
    Inflammation, 2017, 40 : 657 - 665
  • [3] UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?
    Cui, Ji-hong
    Xie, Xin
    INFLAMMATION, 2017, 40 (02) : 657 - 665
  • [4] The regulation of the UCH-L1 gene by transcription factor NF-κB in podocytes
    Zhang, Hongxia
    Sun, Yu
    Hu, Ruimin
    Luo, Weili
    Mao, Xing
    Zhao, Zhonghua
    Chen, Qi
    Zhang, Zhigang
    CELLULAR SIGNALLING, 2013, 25 (07) : 1574 - 1585
  • [5] Prognostic potential and oncogenic effects of UCH-L1 expression in hilar cholangiocarcinoma
    Jin, Yan
    Zhou, Hong
    Gong, Lei
    Xia, Jiazeng
    Yu, Guanzhen
    Chen, Yigang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (11): : 10802 - 10811
  • [6] Wnt/β-catenin pathway involved in podocyte injury is regulated by UCH-L1
    Hu, Ruimin
    Li, Fang
    Fang, Yili
    Mao, Xing
    Liu, Junying
    Xu, Yuyin
    Wu, Huijuan
    Zhang, Zhigang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (11): : 11324 - 11333
  • [7] The functions of UCH-L1 and its relation to neurodegenerative diseases
    Setsuie, Rieko
    Wada, Keiji
    NEUROCHEMISTRY INTERNATIONAL, 2007, 51 (2-4) : 105 - 111
  • [8] Role of the deubiquitinating enzyme UCH-L1 in mitochondrial function
    Bouron, Alexandre
    Aubry, Laurence
    Loreth, Desiree
    Fauvarque, Marie-Odile
    Meyer-Schwesinger, Catherine
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2023, 17
  • [9] Identification of a novel chemical potentiator and inhibitors of UCH-L1 by in silico drug screening
    Mitsui, Takeshi
    Hirayama, Kazunori
    Aoki, Shunsuke
    Nishikawa, Kaori
    Uchida, Kenko
    Matsumoto, Takashi
    Kabuta, Tomohiro
    Wada, Keiji
    NEUROCHEMISTRY INTERNATIONAL, 2010, 56 (05) : 679 - 686
  • [10] Effects of UCH-L1 on α-synuclein over-expression mouse model of Parkinson's disease
    Yasuda, Toru
    Nihira, Tomoko
    Ren, Yong-Ri
    Cao, Xu-Qing
    Wada, Keiichiro
    Setsuie, Rieko
    Kabuta, Tomohiro
    Wada, Keiji
    Hattori, Nobutaka
    Mizuno, Yoshikuni
    Mochizuki, Hideki
    JOURNAL OF NEUROCHEMISTRY, 2009, 108 (04) : 932 - 944